FDA Import Refusal 799-4285177-3/81/1 — Mylan Pharmaceuticals ULC
The FDA refused shipment 799-4285177-3/81/1 from Mylan Pharmaceuticals ULC (Canada) on Nov 26, 2019. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Nov 26, 2019
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61JCA08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
- Charges
- 75